ANNUAL FINANCIAL REPORT 2010 2010 - TiGenix

Current financial assetsShown below are the breakdown and the followingmovements of this caption of the balance sheets:Thousands of Euro (€)DepositsYears ended December 31Current fixed-incomesecurities (bank notes) Loans TotalAt January 1, 2008 - 102 - 102Additions 577 - - 577Disposals - (102) - (102)At December 31, 2008 577 - - 577Additions 222 - 421 643At December 31, 2009 799 - 421 1,220Additions - - - -Transfer 364 - - 364Disposals (484) - (421) (905)At December 31, 2010 679 - - 679These current deposits were pledged to guarantee fulfilmentof the requirements for the award of grants obtained, thepayment of which requires the presentation of a guaranteeequal to the amount of said grants. As these amounts relateto projects for which Cellerix has already presented proof ofcompletion, they have been classified as short-term.Additionally, as of December 31, 2009 this balance includedtwo loans granted in 2009 by the Spanish Ministry of Scienceand Innovation in the amount of €109k and €312k that were noreceived at the end of such year and were collected in 2010.9.1.5.12 InventoriesThe whole balance of this caption relates to raw materialsacquired by Cellerix to be consumed in the course of its clinicaldrug research and development activities.Years ended December 31Thousands of Euro (€) 2010 2009 2008Raw materials and consumables 69 83 18Total inventories 69 83 189.1.5.13 ReceivablesShown below is the break down of the balance of this caption:Thousands of Euro (€) 2010 2009 2008Receivables 35 51 23Recoverable taxes 269 196 778Salary advances 29 20 27Receivable from group companies 11 2 -Other receivables 396 314 1,308Total other accounts receivable 740 583 2,136215 •